
|Articles|July 19, 2019
Validation of defocus tolerance of novel aberration-neutral hydrophobic acrylic monofocal IOL
Author(s)Julianne Mobilian
Eva Liang, MD, discusses the take-home message from her presentation at ASCRS 2019
Advertisement
Eva Liang, MD, discusses the take-home message from the presentation she delivered at the 2019 meeting of the
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves NDA labeling supplement allowing re-administration of iDose TR
2
Opus Genetics launches phase 1/2 MERTK gene therapy trial
3
Dr. Mali’s top 5 predictions in ophthalmology for 2026
4
Cloudbreak Pharma completes FDA end-of-phase-2 meeting for CBT-004 in pinguecula
5



























